Boxed Warnings and Other FDA Communication Tools

被引:0
|
作者
Marks, Norman S. [1 ]
Weiss, Karen [1 ]
机构
[1] US FDA, Silver Spring, MD USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:259 / 260
页数:2
相关论文
共 50 条
  • [2] FDA Boxed Warnings: How to Prescribe Drugs Safely
    O'Connor, Nina R.
    AMERICAN FAMILY PHYSICIAN, 2010, 81 (03) : 298 - 303
  • [4] Prevalence and Therapeutic Classifications of FDA-Approved Prescription Drugs With Boxed Warnings
    Cheng, Christine M.
    DeLizza, Colleen
    Kapusnik-Uner, Joan
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2014, 48 (02) : 165 - 172
  • [5] Coverage of FDA Medication Boxed Warnings in Commonly Used Drug Information Resources
    Cheng, Christine M.
    Guglielmo, B. Joseph
    Maselli, Judy
    Auerbach, Andrew D.
    ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (09) : 831 - 833
  • [6] Prevalence and Therapeutic Classifications of FDA-Approved Prescription Drugs With Boxed Warnings
    Christine M. Cheng
    Colleen DeLizza
    Joan Kapusnik-Uner
    Therapeutic Innovation & Regulatory Science, 2014, 48 : 165 - 172
  • [7] Doing Nothing Is Doing Something: Primary Care Antidepressant Treatment in the Era of FDA Boxed Warnings
    Lacy, Benjamin W.
    Baron, David A.
    Goin, Marcia K.
    Gross, Lawrence S.
    Slaby, Andrew E.
    Sumner, Calvin R.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2013, 113 (02): : 117 - 119
  • [9] Disclosure of Boxed Warnings to Research Participants
    Bhattacharya, Tanya
    Tice, Debra G.
    Lingam, Pranathi
    Florek, Aleksandra
    Yates, Eileen M.
    Weitzman, Sigmund
    Belknap, Steven M.
    JAMA INTERNAL MEDICINE, 2015, 175 (09) : 1567 - 1568